Mark S. Stanley
16Patents
6h-index
41Co-inventors
66Inventor score
Filing activity: Aug 9, 1993 → Feb 4, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6667318B2 | LFA-1 antagonist compounds | Chemistry; Metallurgy | 34 | Expired |
| US6872735B2 | LFA-1 antagonist compounds | Chemistry; Metallurgy | 29 | Expired |
| US5798337A | Low molecular weight peptidomimetic growth hormone secretagogues | Human Necessities | 27 | Expired |
| US8486950B2 | Janus kinase inhibitor compounds and methods | Chemistry; Metallurgy | 23 | Active |
| US7888364B2 | Pyridyl inhibitors of hedgehog signalling | Chemistry; Metallurgy | 7 | Active |
| US7893085B2 | Aza-benzothiophenyl compounds and methods of use | Human Necessities | 6 | Active |
| US6933314B2 | Integrin receptor inhibitors | Chemistry; Metallurgy | 5 | Expired |
| US6034216A | Low molecular weight peptidomimetic growth hormone secretagogues | Human Necessities | 3 | Expired |
| US6706753B2 | Integrin receptor inhibitors | Chemistry; Metallurgy | 3 | Expired |
| US9321761B2 | Pyridyl inhibitors of hedgehog signalling | Chemistry; Metallurgy | 2 | Active |
| US9278961B2 | Pyridyl inhibitors of hedgehog signalling | Chemistry; Metallurgy | 2 | Active |
| US7855216B2 | Aza-indolyl compounds and methods of use | Chemistry; Metallurgy | 1 | Active |
| US7094869B2 | Low molecular weight peptidomimetic growth hormone secretagogues | Chemistry; Metallurgy | 1 | Expired |
| US5942537A | Method of inhibiting the transport of L-glutamate to treat CNS disorders | Chemistry; Metallurgy | 1 | Expired |
| US9790183B2 | Pyridyl inhibitors of hedgehog signalling | Chemistry; Metallurgy | 0 | Active |
| US7265146B2 | Integrin receptor inhibitors | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.